| Literature DB >> 29400698 |
Carly A Dillen1, Bret L Pinsker1, Alina I Marusina2, Alexander A Merleev2, Orly N Farber3, Haiyun Liu1, Nathan K Archer1, Da B Lee1, Yu Wang1, Roger V Ortines1, Steven K Lee1, Mark C Marchitto1, Shuting S Cai1, Alyssa G Ashbaugh1, Larissa S May4, Steven M Holland5, Alexandra F Freeman5, Loren G Miller6, Michael R Yeaman6,7,8,9, Scott I Simon10, Joshua D Milner3, Emanual Maverakis2, Lloyd S Miller1,11,12,13.
Abstract
The mechanisms that mediate durable protection against Staphylococcus aureus skin reinfections are unclear, as recurrences are common despite high antibody titers and memory T cells. Here, we developed a mouse model of S. aureus skin reinfection to investigate protective memory responses. In contrast with WT mice, IL-1β-deficient mice exhibited poor neutrophil recruitment and bacterial clearance during primary infection that was rescued during secondary S. aureus challenge. The γδ T cells from skin-draining LNs utilized compensatory T cell-intrinsic TLR2/MyD88 signaling to mediate rescue by trafficking and producing TNF and IFN-γ, which restored neutrophil recruitment and promoted bacterial clearance. RNA-sequencing (RNA-seq) of the LNs revealed a clonotypic S. aureus-induced γδ T cell expansion with a complementarity-determining region 3 (CDR3) aa sequence identical to that of invariant Vγ5+ dendritic epidermal T cells. However, this T cell receptor γ (TRG) aa sequence of the dominant CDR3 sequence was generated from multiple gene rearrangements of TRGV5 and TRGV6, indicating clonotypic expansion. TNF- and IFN-γ-producing γδ T cells were also expanded in peripheral blood of IRAK4-deficient humans no longer predisposed to S. aureus skin infections. Thus, clonally expanded γδ T cells represent a mechanism for long-lasting immunity against recurrent S. aureus skin infections.Entities:
Keywords: Adaptive immunity; Bacterial infections; Immunology; Infectious disease; Skin
Mesh:
Substances:
Year: 2018 PMID: 29400698 PMCID: PMC5824877 DOI: 10.1172/JCI96481
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808